Amy Hopkin
Director, Search and Evaluation - Eye Care AbbVie
Amy Hopkin is a seasoned leader in pharma and medtech, with over a decade of experience in drug discovery and strategic innovation. She began her career at Allergan/AbbVie as a Discovery Scientist, contributing to early-stage research across therapeutic areas including ophthalmology. She then gained entrepreneurial experience at a medical device startup before returning to AbbVie in 2022 as Director of Search and Evaluation, Eye Care. Amy identifies external opportunities to expand AbbVie’s pipeline. She holds a PhD in Biomedical Sciences from UC Irvine and is passionate about mentoring, travel, and spending time with her family.
Seminars
This panel will discuss collaboration in delivery development i.e., co-developing platforms, managing device timelines, and regulatory alignment in combo products.
- Strategies to leverage the speed and innovation of biotech startups alongside the deep experience and resources of pharma giants like AbbVie: turning potential clashes into powerful synergies
- What “we’re thoroughly enjoying our AbbVie relationship” means in practice: how both Ripple Therapeutics and AbbVie have fostered continuous learning and development through close cooperation during diligence, development planning, and execution phases
- The importance of proactive, transparent communication, and collaboration across functions, including early alignment with device teams and other stakeholders, to anticipate challenges and optimize program success
